All In Biotech

Drug Trial Radar · NCT06165250

A Study to Evaluate the Efficacy and Safety of Co-administrated BR1018B and BR1018C

A Multicenter, Randomized, Double-blind, Active-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Co-administrated BR1018B and BR1018C in Patients With Essential Hypertension and Primary Hypercholesterolemia

Last checked: Nov 19, 2026Latest source record: Aug 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 151 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

151

Actual

Start

Apr 17, 2024

Primary completion

Nov 11, 2025

Study completion Nov 11, 2025

Sponsor

Sponsor type
Industry
First posted
Dec 11, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 19 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this clinical trial is to evaluate the efficacy and safety of co-administrated BR1018B and BR1018C in patients with essential hypertension and primary hypercholesterolemia

Conditions

  • Essential Hypertension
  • Primary Hypercholesterolemia

Interventions

  • BR1018ADrug

    One tablet administered alone

  • BR1018A-1Drug

    One tablet administered alone

  • BR1018BDrug

    One tablet administered alone

  • BR1018B-1Drug

    One tablet administered alone

  • BR1018CDrug

    One tablet administered alone

  • BR1018C-1Drug

    One tablet administered alone

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean sitting systolic blood pressureTime frame: 8weeks from Baseline Visit
  2. LDL-CTime frame: 8weeks from Baseline Visit

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Keimyung University Dongsan Hospital

    Daegu, South Korea

  • Seoul National University Boramae Medical Center

    Seoul, South Korea

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.